NO20044996L - Furylforbindelser - Google Patents

Furylforbindelser

Info

Publication number: NO20044996L
Authority: NO; Norway
Prior art keywords: compounds; furylforbindelser; compositions; therapy; pharmaceutically
Prior art date: 2002-04-18

Application number

NO20044996A

Other languages

English (en)

Norwegian (no)

Inventor

Eifion Phillips

Hui-Fang Chang

Li Yan

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-18

Filing date

2004-11-17

Publication date

2005-01-18

2002-04-18 Priority claimed from SE0201186A external-priority patent/SE0201186D0/xx

2002-12-04 Priority claimed from SE0203607A external-priority patent/SE0203607D0/xx

2004-11-17 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-01-18 Publication of NO20044996L publication Critical patent/NO20044996L/no

Links

150000001875 compounds Chemical class 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20044996A 2002-04-18 2004-11-17 Furylforbindelser NO20044996L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0201186A SE0201186D0 (sv)	2002-04-18	2002-04-18	Furyl compounds
SE0203607A SE0203607D0 (sv)	2002-12-04	2002-12-04	Furyl compounds
PCT/SE2003/000613 WO2003087102A1 (en)	2002-04-18	2003-04-15	Furyl compounds

Publications (1)

Publication Number	Publication Date
NO20044996L true NO20044996L (no)	2005-01-18

Family

ID=29253788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044996A NO20044996L (no)	2002-04-18	2004-11-17	Furylforbindelser

Country Status (15)

Country	Link
US (1)	US7417049B2 (de)
EP (1)	EP1499618B1 (de)
JP (1)	JP4511195B2 (de)
KR (1)	KR20040099447A (de)
CN (1)	CN1325500C (de)
AT (1)	ATE484508T1 (de)
AU (1)	AU2003225456B2 (de)
BR (1)	BR0309343A (de)
CA (1)	CA2482311C (de)
DE (1)	DE60334536D1 (de)
IL (1)	IL164509A0 (de)
MX (1)	MXPA04010191A (de)
NO (1)	NO20044996L (de)
NZ (1)	NZ561794A (de)
WO (1)	WO2003087102A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR036040A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
HUP0402289A2 (hu)	2001-10-02	2005-02-28	Pharmacia & Upjohn Company	Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
BR0309342A (pt) *	2002-04-18	2005-02-15	Astrazeneca Ab	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
EP1678183A1 (de) *	2003-10-21	2006-07-12	AstraZeneca AB	Spirofuropyridinarylderivate
US7045530B2 (en)	2003-12-22	2006-05-16	Abbott Laboratories	Spirocyclic quinuclidinic ether derivatives
TW200813067A (en) *	2006-05-17	2008-03-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
MX2010014203A (es)	2008-06-20	2011-02-22	Astrazeneca Ab	Derivados de dibenzotiazepina y sus usos - 424.
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
AR081402A1 (es)	2010-05-17	2012-08-29	Envivo Pharmaceuticals Inc	Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
PE20130775A1 (es) *	2010-05-27	2013-07-21	Targacept Inc	Antagonistas no competitivos de receptores nicotinicos
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
CA2872005A1 (en)	2012-05-08	2013-11-14	Forum Pharmaceuticals, Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
WO2014122474A1 (en)	2013-02-07	2014-08-14	Takeda Pharmaceutical Company Limited	Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
HK1219722A1 (zh)	2013-06-21	2017-04-13	Takeda Pharmaceutical Company Limited	1-磺酰基派啶衍生物作为前动力蛋白受体的调节剂
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
US10174052B2 (en)	2014-11-04	2019-01-08	Bristol-Myers Squibb Company	Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
CN108003895B (zh) *	2016-10-28	2019-04-19	西安近代化学研究所	一种向列相液晶组合物及其显示元件
CN108018049B (zh) *	2016-10-28	2019-09-27	西安近代化学研究所	具有5,6-二氟取代苯并呋喃环的液晶化合物
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
SG11202010187RA (en)	2018-05-10	2020-11-27	Zoetis Services Llc	Endoparasitic depsipeptides
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
GB202414193D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds
GB202414197D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) *	1999-01-15	1999-01-15	Astra Ab	New compounds
FR2788982B1 (fr)	1999-02-02	2002-08-02	Synthelabo	Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
US6569865B2 (en) *	2001-06-01	2003-05-27	Astrazeneca Ab	Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
DE60218032T2 (de) *	2001-06-01	2007-08-16	Astrazeneca Ab	Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
BR0309342A (pt) *	2002-04-18	2005-02-15	Astrazeneca Ab	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas

2003
- 2003-04-15 EP EP03746523A patent/EP1499618B1/de not_active Expired - Lifetime
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en not_active Ceased
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Ceased
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown

Also Published As

Publication number	Publication date
CA2482311C (en)	2009-12-08
CN1662541A (zh)	2005-08-31
BR0309343A (pt)	2005-02-15
CA2482311A1 (en)	2003-10-23
US7417049B2 (en)	2008-08-26
EP1499618B1 (de)	2010-10-13
WO2003087102A1 (en)	2003-10-23
MXPA04010191A (es)	2005-02-03
JP4511195B2 (ja)	2010-07-28
HK1079519A1 (en)	2006-04-07
NZ561794A (en)	2008-11-28
KR20040099447A (ko)	2004-11-26
US20050176745A1 (en)	2005-08-11
DE60334536D1 (de)	2010-11-25
AU2003225456A1 (en)	2003-10-27
AU2003225456B2 (en)	2009-02-05
ATE484508T1 (de)	2010-10-15
CN1325500C (zh)	2007-07-11
IL164509A0 (en)	2005-12-18
EP1499618A1 (de)	2005-01-26
JP2005533012A (ja)	2005-11-04

Publication	Publication Date	Title
DE60334536D1 (de)	2010-11-25	Furylverbindungen
NO20044995L (no)	2005-01-18	Heterosykliske forbindelser
ATE477256T1 (de)	2010-08-15	Thienylverbindungen
SE0202463D0 (sv)	2002-08-14	Novel compounds
IS7721A (is)	2005-03-01	Píperidín-pýrídasón og þalasón sem PDE4 hemlar
SE0401971D0 (sv)	2004-08-02	Piperidne derivatives
SE0101387D0 (sv)	2001-04-20	Novel compounds
MX2007005933A (es)	2007-06-20	Compuestos de acetamida como fungicidas.
SE0401970D0 (sv)	2004-08-02	Novel compounds
SE0302139D0 (sv)	2003-07-28	Novel compounds
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
SE0301320D0 (sv)	2003-05-06	Positive modulators of nicotinic acetylcholine receptors
ATE457977T1 (de)	2010-03-15	Biguanidderivate
SE0203303D0 (sv)	2002-11-07	Novel Compounds
ATE419242T1 (de)	2009-01-15	Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
GB0229081D0 (en)	2003-01-15	Multifunctional cationic photoinitiators, their preparation and use
SE0300105D0 (sv)	2003-01-16	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0203300D0 (sv)	2002-11-07	Novel Compounds
SE0203302D0 (sv)	2002-11-07	Novel Compounds
DE60316128D1 (de)	2007-10-18	N-sulfonylurea-apoptosis-förderer
NO20030500L (no)	2003-01-31	Dihydroporfyrinderivater og deres anvendelse
MXPA06004299A (es)	2006-06-05	Derivados de arilespirofuropiridina.
DK1638948T3 (da)	2009-02-02	Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere
ATE416162T1 (de)	2008-12-15	Naphthamidderivate und deren verwendung
SE0203301D0 (sv)	2002-11-07	Novel Compounds